News
Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...
Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high ...
(Reuters) -The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who ...
Posay's Effaclar A.Z. Gel-Cream is touted as a skincare unicorn. But is it really as good as everyone says it is?
Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in nAMD, the leading cause of vision loss in people over the age of 60With two refills per year, ...
Swiss officials plan to negotiate urgently for a lower rate, before the punishing levy takes effect next week.
Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...
Prices for the eponymous Swiss watches, Swiss chocolate and Swiss cheese could skyrocket in a week as a result of U.S.
In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months ...
DPIIT collaborates with Roche Products and HDFC Capital Advisors to support startups in healthcare and affordable housing ...
In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...
4d
GlobalData on MSNRoche’s Alzheimer’s therapy shows continued benefitRoche’s Alzheimer’s disease therapy has continued to show benefit for patients after 28 weeks in a long-term extension study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results